Who has invested in Olatec Therapeutics?

Sanders Morris Harris Group are named among the investors backing Olatec Therapeutics.

Olatec Therapeutics Funding: $40M Raised, Series A (2023)

Olatec Therapeutics funding overview

Olatec Therapeutics is based in New York. Olatec Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2023. The round record for Olatec Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Sanders Morris Harris Group.

Olatec Therapeutics at a glance

Total raised: $40M
Latest round: Series A
Latest round date: February 2023
Headquarters: New York
Notable investors: Sanders Morris Harris Group

Frequently asked about Olatec Therapeutics funding

How much has Olatec Therapeutics raised?: Olatec Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Olatec Therapeutics?: Sanders Morris Harris Group are named among the investors backing Olatec Therapeutics.
What was the latest Olatec Therapeutics funding round?: The most recent disclosed round is a Series A, announced in February 2023.
Where is Olatec Therapeutics based?: Olatec Therapeutics is based in New York.
When did Olatec Therapeutics last raise?: The last disclosed Olatec Therapeutics round closed in February 2023 at Series A.

Totals shown for Olatec Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in New York and the investors behind them below.

Olatec Therapeutics Funding: $40M Raised, Series A (2023)

Olatec Therapeutics funding overview

Olatec Therapeutics at a glance

Frequently asked about Olatec Therapeutics funding

Companies related to Olatec Therapeutics (18)

Browse related funding lists (5)